[1]
2019. How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS). Brazilian Journal of Pharmaceutical Sciences. 55, (Nov. 2019), e17197. DOI:https://doi.org/10.1590/s2175-97902019000117197.